AwardsFY25Data.pdf
PDF 229 KB Posted
- Attached to
- FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- Solicitation number
- FDABAA-25-00123_Award
About this file
This document is a federal contract award summary table listing multiple contract awards from various centers within a government agency. The table contains 16 contracts totaling $14,851,287.78, with recipients including universities, research institutions, and private companies. Contract amounts range from $288,274 to $3,090,714.59, awarded across different centers such as CDER, OCE, CDRH, and CTP. The awards cover diverse research topics including machine learning, clinical trial design, medical countermeasures, bioprocess operations, vaccine research, patient preference studies, and digital health innovations. Each contract is associated with a specific BAA (Broad Agency Announcement) number and charge/topic designation, indicating a structured research funding approach targeting advanced scientific and medical research initiatives.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| BAATrackingSheet_AwardsFY25Data-01-08-2026.pdf | ||
| BAATrackingSheet_AwardsFY25Data-11-20-25.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Contract Number Amount Obligated
Total Estimated
Contract Value Center Awardee Name Awardee Address Column1 Column2 BAA Number Award Title
75F40125C00073 $661,012.30 $661,012.30 CDER SimVantage GmbH
SIMVANTAGE GMBH
Inffeldgasse 13
Graz 8010 Charge I Topic B FY25C1BP3
Combining Machine Learning and Mechanistic Models to Create a Digital Framework for Rapidly Designing
Continuous Bioprocess Operations
75F40125C00085 $324,978.00 $324,978.00 CDER Hartford Hospital
80 Seymour St
PO Box 5037
Hartford, CT 06102 Charge III Topic B FY25C3BP2
Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine
Thigh Infection Model
75F40125C00095 $3,090,714.59 $3,090,714.59 OCS Vahan Simonyan
3909 Fox Valley Rd
Rockville,MD
20853 Charge III Topic A FY25C3AP3
HIVE 2.O (H2O) – a next generation medical countermeasures scientific platform for regulatory evaluation and preparedness
75F40125C00089 $999,347.00 $999,347.00 CDER Rutgers University
3 RUTGERS PLAZA
NEW BRUNSWICK NJ 089018559 Charge I Topic B FY25C1BP27
Development and implementation of AI/ML toolbox for digitalization of advanced modular continuous API manufacturing process
75F40125C00069 $1,085,530.00 $1,085,530.00 CDER Genentech Inc.
GENENTECH, INC.
1 DNA WAY
SOUTH SAN FRANCISCO CA 94080 Charge I Topic F FY25C1FP4
Novel hybrid randomized clinical trial designs for longitudinal outcomes with applications to rare disease settings
75F40125C00075 $1,064,238.00 $1,064,238.00 OCE
The University of Texas MD
Anderson Cancer Center
THE UNIVERSITY OF TEXAS M D
ANDERSON CANCER
1515 HOLCOMBE BLVD
Box 1676
HOUSTON TX 77030 Charge I Topic F FY25C1FP6 Statistical designs and considerations for dose optimization with drug combination and multiple indications
75F40125C00072 $799,998.00 $799,998.00 CDER
The National Center for Natural
Products Research (NCNPR), The University of Mississippi
THE UNIVERSITY OF MISSISSIPPI
SPONSORED PROGRAMS
ADMINISTRATION
UNIVERSITY OF MISSISSIPPI
P.O. Box 1848
100 Barr Hall
UNIVERSITY MS 386779704 Charge I Topic C FY25C1CP32 Quality and Safety of Botanical Products: Addressing Herb-Drug Interactions in Healthy Individuals
75F40125C00105 $2,277,208.00 $2,277,208.00 CDRH
Florida State University, Center of Population Sciences for
Health Equity
874 Traditions Way
Tallahassee, FL 32306 Charge III Topic C FY25C3CP4
Modernizing and Decentralizing Clinical Trials with AI, Digital Health, and Community-Driven Innovation to
Deliver Better Health for All Americans
75F40125C00034 $867,755.00 $1,981,317.00 CTP
The Ohio State University
College of Public Health
OHIO STATE UNIVERSITY, THE 1960
KENNY RD
COLUMBUS OH 43210 Charge I Topic C FY25C1CP40
The Determination of Repeatability (r) and Reproducibility (R) for the measurement of total particulate matter and nicotine in combustible and electronic nicotine delivery systems (ENDS) using a universal smoking machine adaptor (USMA).
75F40125C00054 $1,138,631.00 $1,138,631.00 OCE
Johns Hopkins University School of Medicine
W-400 WYMAN PARK
3400 N CHARLES ST
JOHNS HOPKINS UNIVERSITY
BALTIMORE MD 212182685 Charge II Topic D FY25C2DP7
Application of Computable Phenotyping to Real-World Data to Support the Active Safety Surveillance of
CAR T-cell Therapies
75F40125C00071 $492,000.00 $1,265,103.00 OCET
University of Maryland, Baltimore
UNIVERSITY OF MARYLAND, BALTIMORE
220 ARCH STREET, OFFICE LEVEL 2
BALTIMORE MD 212011531 Charge III Topic A FY25C3AP15 Noninvasive Fingerprinting of Aluminum-adjuvanted Vaccines
75F40125C00053 $749,661.00 $749,661.00 CDRH Duke University
Duke University
2200 WEST MAIN STREET SUITE 300
DURHAM NC 27705
Charge I Topic I FY25C1IP7 Quantifying Patient Preference Information in Small-Scale Studies for Regulatory Decision Making
75F40125C00049 $288,274.00 $288,274.00 CDER
University of Maryland
Baltimore
THE STATE OF MARYLAND 1378167
UNIVERSITY OF MARYLAND BALTIMORE
601 W LOMBARD ST
BALTIMORE MD 21201 Charge III Topic B FY25C3BP5
Developing studies needed to define clinical and/or surrogate endpoints that can be used for the regulatory approval of decolonizing agents, microbiome therapies, or similar products
75F40125C00063 $515,769.89 $515,769.89 Universitat St Gallen
DUFOURSTRASSE 40A ST. GALLEN SG
9000 Charge II Topic D FY25C2DP1 RiskExcellence – Complementing Risk-Based Surveillance
75F40125C00009 $496,171.00 $496,171.00 CDRH DIGITAL MEDICINE SOCIETY INC 90 CANAL ST FL 4, BOSTON MA 02114 Charge I Topic I FY24C1IP4
Vision 2030: Strategic roadmap for implementing patient voice into the total product lifecycle for medical devices via patient-generated health data
$14,851,287.78 $16,737,952.78
File details come from the government source that posted it. Updated .